NALTREXONE HCL 50 MG ORAL TABLET

Clinical trials for NALTREXONE HCL 50 MG ORAL TABLET explained in plain language.

Never miss a new study

Get alerted when new NALTREXONE HCL 50 MG ORAL TABLET trials appear

Sign up with your email to follow new studies for NALTREXONE HCL 50 MG ORAL TABLET, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Grief drug trial stalls: naltrexone study halted after just 7 participants

Symptom relief Terminated

This study tested whether the drug naltrexone could help people with prolonged grief disorder, a condition where intense grief lasts for a long time. Only 7 people took part, and the study was stopped early. Participants took the drug or a placebo for 8 weeks and had monthly chec…

Matched conditions: NALTREXONE HCL 50 MG ORAL TABLET

Phase: PHASE4 • Sponsor: Texas Tech University • Aim: Symptom relief

Last updated May 26, 2026 12:05 UTC

NALTREXONE HCL 50 MG ORAL TABLET

Get alerted when new NALTREXONE HCL 50 MG ORAL TABLET trials appear

Grief drug trial stalls: naltrexone study halted after just 7 participants